What does Remeditex Ventures invest in?
Remeditex Ventures invests most often at Series B and Series C (88% of the rounds on record), in sectors such as Biotechnology and Health Care.
Last cheque observed Nov 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietVC firm
8 rounds on record
Mostly Series B and Series C: 88% of its rounds
Every round we can evidence, newest first8 appearances
2 rounds
2 rounds
3 rounds
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as Remeditex Ventures. A count of rooms they were both in, not a relationship either has claimed.
Remeditex Ventures invests most often at Series B and Series C (88% of the rounds on record), in sectors such as Biotechnology and Health Care.
8 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2015.
The median round it joins is $16M.
Rarely, if at all: none of its 8 investments on record names it as the lead.
Most of the companies it backs are in the United States (100%).
No investments in the last 12 months; the latest was in Nov 2015.
Most often Atlas Venture (4 rounds together), Boulder Ventures (4 rounds together) and Amgen Ventures (3 rounds together).
Remeditex Ventures is a VC firm.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it